Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12Stomach Neoplasms 4Prostatic Neoplasms 4Polycystic Ovary Syndrome 4Neoplasms 3Peripheral Nervous System Diseases 2Lung Neoplasms 2Inflammation 2Esophageal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Intraductal, Noninfiltrating 2Weight Loss 1Rectal Neoplasms 1Psychological Well-Being 1Psoriasis 1Protein Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasm, Residual 1Multiple Sclerosis 1Multiple Myeloma 1Motor Activity 1Malnutrition 1Lipid Metabolism Disorders 1Healthy Subject 1

Interventions

fludarabine 2Fingolimod Hydrochloride 2Cyclophosphamide 2Blood Specimen Collection 2teriflunomide 1gadobutrol 1gadobenic acid 1Surveys and Questionnaires 1Specimen Handling 1Respiratory Therapy 1Registries 1Platelet Transfusion 1Phlebotomy 1OM 89 1Nivolumab 1Natalizumab 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Interferon beta-1a 1Gadolinium DTPA 1Fish Oils 1Exergaming 1Dimethyl Fumarate 1Dietary Fiber 1Data Collection 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multiple Sclerosis × Fish Oils × Clear all
NCT02939079 2019-05-14

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Isfahan University of Medical Sciences

Phase 2/3 Completed
50 enrolled 20 charts

Multiple Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡